Wei Wu1, Zhibing Lu2, Yuanhong Li3, Zhiqiang Chen4, Hong Jiang5, Yan Li1. 1. Department of Clinical Laboratory; 2. Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan; ; Department of Cardiology, Central Hospital of Huangshi, Huangshi; 3. Department of Cardiology, Central Hospital of Enshi Autonomous Prefecture, Enshi, China. 4. Department of Cardiology, Central Hospital of Huangshi, Huangshi; 5. Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan;
Abstract
BACKGROUND: The objective of this study was to compare the expression of heat shock proteins (HSPs) between rheumatic heart disease (RHD) patients with atrial fibrillation (AF) and RHD patients without AF, and its efficacy in predicting the occurrence of AF in RHD patients. METHODS: Ninety-five patients were enrolled in our study, including 60 RHD patients with AF, and 35 RHD patients without AF. The baseline characteristics of the patients such as gender, age, AF duration, left atrial diameter and left ventricular ejection fraction were collected, and erythrocyte sedimentation rate and high-sensitivity C-reaction protein were measured from all patients. Tissue samples were obtained from the right atrial appendage during open-heart surgery and then detected using immunohistochemical methods and Western blot with HSP27, HSP60, HSP70 and HSP90 antibodies. RESULTS: Compared with RHD patients without AF, the density of HSP27 positive protein in RHD patients with AF was significantly lower. The density of HSP60, HSP70 or HSP90 antibodies did not indicate significant difference between the two groups. Use of the Western blot experiment showed consistent results with immunohistochemical staining. In RHD patients with AF, the expression level of HSP27 protein was negatively associated with AF duration and left atrial diameter. Left atrial enlargement and low expression of HSP27 were the independent predictors of AF. CONCLUSIONS: The decreased expression level of HSP27 is associated with AF in RHD patients. KEY WORDS: Atrial fibrillation; Heat shock protein; Rheumatic heart disease.
BACKGROUND: The objective of this study was to compare the expression of heat shock proteins (HSPs) between rheumatic heart disease (RHD) patients with atrial fibrillation (AF) and RHD patients without AF, and its efficacy in predicting the occurrence of AF in RHD patients. METHODS: Ninety-five patients were enrolled in our study, including 60 RHD patients with AF, and 35 RHD patients without AF. The baseline characteristics of the patients such as gender, age, AF duration, left atrial diameter and left ventricular ejection fraction were collected, and erythrocyte sedimentation rate and high-sensitivity C-reaction protein were measured from all patients. Tissue samples were obtained from the right atrial appendage during open-heart surgery and then detected using immunohistochemical methods and Western blot with HSP27, HSP60, HSP70 and HSP90 antibodies. RESULTS: Compared with RHD patients without AF, the density of HSP27 positive protein in RHD patients with AF was significantly lower. The density of HSP60, HSP70 or HSP90 antibodies did not indicate significant difference between the two groups. Use of the Western blot experiment showed consistent results with immunohistochemical staining. In RHD patients with AF, the expression level of HSP27 protein was negatively associated with AF duration and left atrial diameter. Left atrial enlargement and low expression of HSP27 were the independent predictors of AF. CONCLUSIONS: The decreased expression level of HSP27 is associated with AF in RHD patients. KEY WORDS: Atrial fibrillation; Heat shock protein; Rheumatic heart disease.
Authors: Bianca J J M Brundel; Akiko Shiroshita-Takeshita; Xiaoyan Qi; Yung-Hsin Yeh; Denis Chartier; Isabelle C van Gelder; Robert H Henning; Harm H Kampinga; Stanley Nattel Journal: Circ Res Date: 2006-11-16 Impact factor: 17.367
Authors: Bianca J J M Brundel; Robert H Henning; Lei Ke; Isabelle C van Gelder; Harry J G M Crijns; Harm H Kampinga Journal: J Mol Cell Cardiol Date: 2006-07-31 Impact factor: 5.000
Authors: K Ikeda; T Monden; T Kanoh; M Tsujie; H Izawa; A Haba; T Ohnishi; M Sekimoto; N Tomita; H Shiozaki; M Monden Journal: J Histochem Cytochem Date: 1998-03 Impact factor: 2.479
Authors: Bianca J J M Brundel; Lei Ke; Anne-Jan Dijkhuis; XiaoYan Qi; Akiko Shiroshita-Takeshita; Stanley Nattel; Robert H Henning; Harm H Kampinga Journal: Cardiovasc Res Date: 2008-03-07 Impact factor: 10.787
Authors: Alfons E Schäfler; Kiriakos Kirmanoglou; Jochen Balbach; Peter Pecher; Andreas Hannekum; Bernd Schumacher Journal: Basic Res Cardiol Date: 2002-05 Impact factor: 17.165